Literature DB >> 2719106

Medium-chain fatty acids increase glucose production in normal and low birth weight newborns.

P F Bougnères1, L Castaño, F Rocchiccioli, H P Gia, B Leluyer, P Ferré.   

Abstract

To study the pathogenesis of hypoglycemia in low birth weight infants, glucose production was measured in five hypotrophic and four premature newborns with glycemia of 45 +/- 6 and 59 +/- 10 mg/dl, respectively. Hepatic glucose output averaged 5.7 +/- 0.4 and 5.3 +/- 0.5 mg.kg-1.min-1 in these neonates vs. 8.2 +/- 0.5 mg.kg-1.min-1 in five normal at term newborns and was correlated with glycemia (P less than 0.02). Despite normal plasma free fatty acids, the low birth weight infants had low ketone levels of 163 +/- 72 and 126 +/- 65 vs. 263 +/- 60 microM in normals. Oral administration of medium-chain triglycerides to the neonates increased their circulating ketones by two- to threefold and restored near-normal glycemia (51 +/- 9 and 76 +/- 8 mg/dl) and production of glucose (6.7 +/- 0.7 and 6.6 +/- 0.8 mg.kg-1.min-1) in the hypotrophic and premature vs. normals (8.7 +/- 0.7 mg.kg-1.min-1). Individual rates of glucose production correlated with ketone concentrations (P less than 0.02). We conclude that the hypoglycemia characterizing low birth weight neonates is primarily due to impaired glucose production. That exogenous lipids were able to increase glucose production indicates that fatty acid oxidation plays an important glucoregulatory role in the human newborn.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719106     DOI: 10.1152/ajpendo.1989.256.5.E692

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Effect of continuous enteral medium-chain fatty acid infusion on lipid metabolism in rats.

Authors:  Y Q You; P R Ling; Z Qu; B R Bistrian
Journal:  Lipids       Date:  1998-03       Impact factor: 1.880

2.  Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

Authors:  C Fanelli; S Calderone; L Epifano; A De Vincenzo; F Modarelli; S Pampanelli; G Perriello; P De Feo; P Brunetti; J E Gerich
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.